| 摘要 |
Compositions and methods of treating both the positive and negative or cognitive symptoms of schizophrenia are disclosed. More specifically, pharmaceutical compositions for oral administration comprising at least one antipsychotic agent in an amount that is effective for treating a positive symptom of schizophrenia and at least one colonically absorbable form of levodopa in an amount that is effective for treating a negative or cognitive symptom of schizophrenia and the use of such compositions for treating schizophrenia are disclosed.
|
